Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
Attar, E. C., DeAngelo, D. J., Supko, J. G., D'Amato, F., Zahrieh, D., Sirulnik, A., Wadleigh, M., Ballen, K. K., McAfee, S., Miller, K. B., Levine, J., Galinsky, I., Trehu, E. G., Schenkein, D., NeubVolume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-07-4626
Date:
March, 2008
File:
PDF, 227 KB
english, 2008